For The Consortium

Public-Private Partnerships Key Function Committee


The mission of the Public-Private Partnerships Key Function Committee is to facilitate the implementation of partnerships and collaborations with industry, other academia and patient advocacy groups, and others within the consortium. This Key Function Committee aims (1) to share best practices across the CTSAs, (2) coordinate CTSA Consortium-wide exchange of information, (3) identify NIH programs and initiatives that help initiate collaborations and facilitate commercialization and (4) provide assistance with new or established partnerships to identify partners and partnership models.



The CTSA Public-Private Partnership KFC is pleased to announce CTSA-IP, an IP aggregating web-based search engine at:

The purpose of the website is to aggregate and market technologies from CTSA institutions as well as those of the National Institutes of Health, with the goal of enhancing research activity and private partnerships across the CTSA consortium. The website includes a text-searchable interface and regular, automatic updating with a standardized template to facilitate broad participation by CTSA consortium members. Currently, there are 15 CTSAs contributing information on their technologies to the site. CTSA institutions that wish to join should contact Mike Hazard at the University of Rochester (

CTSA Pharmaceutical Assets Portal

The CTSA Pharmaceutical Assets Portal "matches" researchers with investigational drugs and/or biologics that may be useful in elucidating disease mechanisms and/or new uses for clinical treatment.

New Resource:

New Resources for Streamlining Clinical Trial and Material Transfer Agreements

NCRR would like to bring to your attention some efforts now underway to streamline clinical trial and material transfer agreement negotiations between industry and academic research centers.

The National Cancer Institute’s Standard Terms of Agreement for Research Trial (START) Clauses focus on company-sponsored and investigator-initiated clinical trial agreements. These contain model language on key concept areas including intellectual property, study data, indemnification, subject injury, confidentiality, and publication rights. For additional information, visit

The Institute of Medicine offers similar resources at, including:

  • A clinical trial agreement template intended for use between an industry sponsor and an academic research center in a sponsor-initiated, Phase 2 or Phase 3 multi-center clinical trial.
  • A material transfer agreement intended for use in connection with transfers of materials other than biological materials, such as small molecule compounds, from a for-profit entity to an academic research institution for use in research that is not funded by the for-profit entity.

H. Gilbert Smith, Ph.D., Office of Corporate Collaborations, Duke University School of Medicine, who is active in NCRR’s Clinical and Translational Science Award (CTSA) Consortium, has prepared a comparison of the NCI and IOM CTA and MTA provisions.


Public-Private Partnerships Groups:
Aggregating Intellectual Property and Resources

Public-Private Partnerships Participants:
Co-Chair(s) Ken Holroyd (Vanderbilt)
Marc S. Malandro (Pittsburgh)
NIH Coordinator(s) Gregory L. Evans (NCI)
Lili Portilla (NCRR)
PI Liaison(s) Eric Orwoll (OHSU)
Eric J. Topol (Scripps)
Project Manager(s) Mehrnama, Sum
Participation Click to view
Next Meetings November 19, 2010
3:00 PM - 4:30 PM

December 22, 2010
3:00 PM - 4:30 PM

Previous Meetings
October 27, 2010
September 29, 2010
August 25, 2010
July 28, 2010
June 23, 2010
May 26, 2010
March 24, 2010
February 24, 2010
February 17, 2010
January 27, 2010
Previous Meetings
October 28, 2009
September 23, 2009
June 24, 2009
May 27, 2009
April 24, 2009
April 22, 2009
March 25, 2009
February 25, 2009
January 28, 2009
Previous Meetings
December 15, 2008
October 29, 2008
September 24, 2008
August 27, 2008
August 26, 2008
August 18, 2008
August 6, 2008
July 30, 2008
June 25, 2008
May 28, 2008
April 30, 2008
January 30, 2008
Previous Meetings
November 28, 2007
September 25, 2007
June 6, 2007